Lung cancer survival rate increases by 73% if caught early
A major lung cancer screening trial, conducted by experts at the University of Liverpool, has found
that patients with a high risk of
developing lung cancer can be identified
with early stage disease and have up to a
73% chance of surviving five years or
more.
The UK Lung Cancer Screening Trial
(UKLS) was undertaken in partnership
with Liverpool Heart & Chest
Hospital, Papworth Hospital and the Royal Brampton & Harefield Hospital with the aim of
highlighting the need for a screening programme to help benefit people who are at risk of developing
lung cancer.
The Chief Investigator of the UKLS trial is Progessor Jogn Field, who is based in the University’s
Institute of Translational Medicine.
Identifying those at risk
Lung cancer kills more people than any other cancer. The number of deaths in 2012 in the UK
was 35,370, making lung cancer the commonest cause of cancer death in the UK for both
men and women.
The main reasons why lung cancer outcomes are so poor, are that approximately 70% of
patients first present to specialist care with incurable advanced disease and current
treatment at this late stage has very little effect on mortality.
However, if a patient’s lung cancer is identified at an early stage, then the clinical outcome is
greatly improved. Individuals with very early stage disease have up to a 73% chance of
surviving for five years or more and over 80% have had surgical interventions. As a result
there is a major national and international focus on CT screening trials.
National screening programme
The results of the UKLS trial provide further evidence for the UK National Screening
Committee (UKNSC) to consider when making a decision whether to implement a national
screening programme in the UK in the future.
Funded by the NIHR Health Technology Assessment Programme the trial was the first and
only lung cancer screening trial to take […]